Role of microRNA-33a in malignant cells

Chang Gao1,2, Jiaen Wei1,2, Tingting Tang1,2

  • 1Key Laboratory for Research and Development of Natural Drugs of Guangdong Province, School of Pharmacy, Guangdong Medical University, Dongguan, Guangdong 523808, P.R. China.

Oncology Letters
|August 13, 2020
PubMed

Insights

MicroRNAs (miRNAs) regulate genes involved in cell processes. This review details miR-33a's role in over a dozen cancers, highlighting its potential as a therapeutic target for cancer prevention and treatment.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Cancer is a leading cause of global mortality and morbidity.
  • MicroRNAs (miRNAs) are small non-coding RNAs regulating gene expression in crucial cellular processes.
  • Aberrant miRNA expression is linked to various diseases, including cancer, with miRNAs classified as oncogenic or tumor suppressive.

Purpose of the Study:

  • To review the multifaceted roles of miR-33a in diverse cancer types.
  • To elucidate the underlying molecular mechanisms of miR-33a's involvement in carcinogenesis.
  • To provide a comprehensive guide for researchers on miR-33a's function in cancer.

Main Methods:

  • Literature review of studies investigating miR-33a in cancer.
  • Analysis of miR-33a's regulatory functions in cellular processes like proliferation, differentiation, metastasis, and apoptosis.
  • Examination of miR-33a's connection to cholesterol metabolism and its implications in carcinogenesis.

Main Results:

  • miR-33a plays significant roles in over a dozen types of cancer.
  • The expression patterns and functions of miR-33a can be either oncogenic or tumor suppressive depending on the cancer context.
  • miR-33a influences cellular cholesterol uptake and synthesis, processes closely tied to cancer development.

Conclusions:

  • miR-33a is a critical regulator implicated in various cancers.
  • Understanding miR-33a's mechanisms offers potential for novel cancer prevention and treatment strategies.
  • This review serves as a valuable resource for researchers exploring miR-33a in oncology.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.1K